Plasma Levels of Soluble Tumor Necrosis Factor Receptor Type I During the Acute Phase Following Complicated Myocardial Infarction Predicts Survival in High-Risk Patients
- 6 December 2005
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 46 (11), 2018-2021
- https://doi.org/10.1016/j.jacc.2005.08.039
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Tumor Necrosis Factor-α Receptor 1 Is a Major Predictor of Mortality and New-Onset Heart Failure in Patients With Acute Myocardial InfarctionCirculation, 2005
- Prognostic value of osteoprotegerin in heart failure after acute myocardial infarctionJournal of the American College of Cardiology, 2004
- N -Terminal Pro–Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery DiseaseCirculation, 2003
- Immunomodulating Therapy: New Treatment Modality in Congestive Heart FailureCongestive Heart Failure, 2003
- Inflammatory Mediators and the Failing HeartCirculation Research, 2002
- Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trialThe Lancet, 2002
- Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart FailureCirculation, 2000
- Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trialsJournal of the American College of Cardiology, 1999
- Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1999